Customise results display
Results 1-6 of 6 (Search time: 0.004 seconds).
|15-Oct-2013||Receptor for advanced glycation end products and soluble receptor for advanced glycation end products: A balancing act in chronic obstructive pulmonary disease?||Sukkar, MB; Postma, DS|
|1-Nov-2012||RAGE: A new frontier in chronic airways disease||Sukkar, MB; Ullah, MA; Gan, WJ; Wark, PAB; Chung, KF; Hughes, JM; Armour, CL; Phipps, S|
|1-Dec-2013||RAGE and TLRs: Relatives, friends or neighbours?||Ibrahim, ZA; Armour, CL; Phipps, S; Sukkar, MB|
|18-Jan-2017||RAGE deficiency predisposes mice to virus-induced paucigranulocytic asthma||Arikkatt, J; Ullah, MA; Short, KR; Zhang, V; Gan, WJ; Loh, Z; Werder, RB; Simpson, J; Sly, PD; Mazzone, SB; Spann, KM; Ferreira, MAR; Upham, JW; Sukkar, MB; Phipps, S|
|1-Jan-2014||Receptor for advanced glycation end products and its ligand high-mobility group box-1 mediate allergic airway sensitization and airway inflammation||Ullah, MA; Loh, Z; Gan, WJ; Zhang, V; Yang, H; Li, JH; Yamamoto, Y; Schmidt, AM; Armour, CL; Hughes, JM; Phipps, S; Sukkar, MB|
|1-Mar-2012||Soluble RAGE is deficient in neutrophilic asthma and COPD||Sukkar, MB; Wood, LG; Tooze, M; Simpson, JL; McDonald, VM; Gibson, PG; Wark, PAB|